Home / Press Release / Global Drug Discovery Informatics Market 2015 to 2022, Analysis, Competitive Strategies and Forecasts – Acute Market Reports

Global Drug Discovery Informatics Market 2015 to 2022, Analysis, Competitive Strategies and Forecasts – Acute Market Reports

According to Stratistics MRC, the Global Drug Discovery Informatics Market is accounted for $1.91 billion in 2015 and is expected to reach $6.94 billion by 2022 growing at a CAGR of 17.5% from 2015 to 2022. The rising demand for computational technology is the primary factor favouring the market growth. Furthermore, Drug discovery industry and rising number of technologically advanced products are the key drivers for the Drug Discovery Informatics market. However, Lack of information technology and critical attributes of data evaluation are limiting the market growth.

Browse Full Report here: http://www.acutemarketreports.com/report/drug-discovery-informatics-global-market-outlook-2015-2022

The recent trends in Drug Discovery Informatics are considerable shift observed from traditional in-vitro drug development to computer aided drug designing, as costly failures of late drug development increases the use of in-silico models for early ADME/Toxicity screening.
Sequence analysis platforms services accounted the largest revenue share and are expected to continue and dominate the market over the forecast period. North America commanded the largest share driven by the increasing demand for computational technology. However, Asia Pacific is projected to register the fastest growth over the forecast period owing to technological developments in the software and drug nano technology fields carried out in the developing economies.

Browse All Reports of This Category @ http://www.acutemarketreports.com/category/market-research

Some of the key players in the market include ChemAxon, GVK Biosciences, Jubilant Biosys, Selvita, Certara, Infosys, Albany Molecular Research Inc., BoehringerIngelheim GmBh,, DiscoverX, Charles River Laboratories, Covance, Collaborative Drug Discovery Inc., Novo Informatics, UCB and Evotec.
Modes Covered:
• In-house Informatics
• Outsourced Informatics
Services Covered:
• Molecular Modelling
• Sequence Analysis Platforms
• Docking
• Clinical Trial Data Management
• Other Services

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

Latest Reports:

About – Acute Market Reports:

Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements. We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends.

Our team consists of highly motivated market research professionals and they are accountable for creating the groundbreaking technology that we utilize in our search engine operations to easily recognize the most current market research reports online.

Contact Us:

Chris Paul

ACUTE MARKET REPORTS

Office No 101, 1st Floor ,

Aditi Mall, Baner,

Pune, MH, 411045

India

Toll Free (US/CANADA): +1-855-455-8662

Email:  sales@acutemarketreports.com

Website: http://www.acutemarketreports.com

Release ID: 2452

About Chris Paul

Check Also

180-180

Global Catalyst Market is Expected to reach $40,000 million with a CAGR of 4.8% Forecast by 2022 – Acute Market Reports

Catalyst Market Overview Catalyst market was valued at $28,567 million, and is expected to reach ...